MoMelan Technologies, which obtained $2.9 million in May, has stretched that figure to $4.8 million in its latest funding round. The Cambridge, Mass.-based firm, which hopes to raise a total of $5 million, is working on a device that can cut the cost and time it takes to graft harvested skin onto a patient.

Related Summaries